This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Sagent Pharmaceuticals nets $98.4mm through its IPO
Sagent Pharmaceuticals Inc. (generic injectable drugs) has netted $98.4mm through its initial public offering of 6.6mm common shares (including the overallotment) at $16 each, the high end of its proposed $14-16 range. The company also sold more stock than it planned--it was gearing towards only 5mm shares.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?